SYNVISC ( Hylan G-F 20) is used to treat pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non pharmacologic therapy and simple analgesics, e.g., acetaminophen.
Manufacturer : Sanofi Genzyme
Strengths available : 2 ml
Storage : Store at temperature below 30°C
FDA approved : Its US FDA approved
Dosage : The recommended dosage for Synvisc is three 2 mL injections in the knee, with an interval of 1 week between each injection. To achieve maximum effect, it is essential to administer all three injections. The maximum recommended dosage is six injections within six months, with a minimum of four weeks between treatment regimens.
Common side effects are Hives, difficult breathing, swelling of your face, lips, tongue, or throat, warmth, pain, stiffness, swelling, or puffiness where the medicine was injected, muscle pain, trouble walking , fever, chills, nausea, numbness or tingly feeling, headache, dizziness, tired feeling, or itching.
Pack of 3 Syringes 2ml each